Citation Numbers: 69 A.D.3d 455, 894 N.Y.2d 21
Filed Date: 1/14/2010
Status: Precedential
Modified Date: 11/1/2024
The motion court, after correctly finding that the admissions were not germane to the diagnosis or treatment of plaintiffs’ injuries and therefore were not admissible under the business records exception to the hearsay rule (see Quispe v Lemle & Wolff, Inc., 266 AD2d 95 [1999]), ruled that the records were to be redacted to omit statements that plaintiffs were applying the polyurethane. In addition, apparently addressing the exception to the hearsay rule for admissions against interest in hospital records (see Coker v Bakkal Foods, Inc., 52 AD3d 765 [2008], lv denied 11 NY3d 708 [2008]), the court ruled that the statements were unreliable, and therefore inadmissible, in view of uncontradicted evidence about the effects of the morphine that was administered to plaintiffs during treatment. This was error. The evidence concerning the effects of the morphine goes to the weight to be accorded the admissions, not their admissibility (see Gangi v Fradus., 227 NY 452, 457 [1920]).
The statements that plaintiffs were applying the polyurethane may only be admitted if there is clear evidence connecting the
To the extent not mooted by post-motion depositions, the motion court properly denied those branches of Alps’ motions that sought vacatur of the note of issue and commissions for further depositions (see Scocozza v Tolia, 254 AD2d 475 [1998]). Concur—Gonzalez, EJ., Tom, Sweeny, Freedman and AbdusSalaam, JJ.